Arcus Biosciences, Inc. RCUS
- quemliclustat — Pancreatic Cancer Phase 3
CD73 (4 companies · 4 programs)
Companies with an active program directed at CD73.
Corvus Pharmaceuticals, Inc. CRVS
- mupadolimab
NovaBridge Biosciences NBP
- uliledlimab — Non-Small Cell Lung Cancer Phase 2
Oric Pharmaceuticals, Inc. ORIC
- ORIC-533 — Relapsed/Refractory Multiple Myeloma Phase 1